Barometer Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Barometer Capital Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,400	Closed	-$298K	–	218
2024 Q1	$298K	Buy	+3,400	New	+$298K	0.08%	141
2022 Q3	–	Sell	-5,900	Closed	-$466K	–	91
2022 Q2	$466K	Buy	+5,900	New	+$461K	0.19%	56
2015 Q3	–	Sell	-12,100	Closed	-$856K	–	174
2015 Q2	$856K	Buy	+12,100	New	+$871K	0.07%	104
2014 Q2	–	Sell	-10,600	Closed	-$618K	–	131
2014 Q1	$618K	Buy	+10,600	New	+$599K	0.13%	80

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

FPGK

Financial Partners Group (Kansas) Overland Park, Kansas $985M AUM 29.69% 1-Year Est. Return

Barometer Capital Management's PPH Position: Q2 2024 in Review

Barometer Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2024, closing a stake of 3,400 shares — an estimated $298K sold.

Barometer Capital Management first reported a position in PPH in Q1 2014 and held it in 4 quarters. The position peaked at $856K in Q2 2015. 140 funds tracked by Wall St. Rank hold PPH as of Q2 2024.

Barometer Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2024 after selling out during the quarter.
Barometer Capital Management sold 3,400 VanEck Pharmaceutical ETF shares in Q2 2024, an estimated $298K.
Barometer Capital Management first reported a position in VanEck Pharmaceutical ETF in Q1 2014 and held it in 4 quarters.
Barometer Capital Management's VanEck Pharmaceutical ETF position peaked at $856K in Q2 2015.
140 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2024.

Based on Barometer Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.